MENU

BBI

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Brickell Biotech (BBI) Ownership - Who owns Brickell Biotech?

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

5777 Central Avenue

Phone

+1 720 505-4755

Employees

16

Web

https://www.brickellbio.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

6.75M

P/E Ratio

N/A

Total Cash

14.48M

Projected Growth

N/A

Total Debt

36K

Revenue

4.64M

Risk (Beta)

0.11

Dividend Yield

N/A

Total Cash/Share

5.04

Total Debt/Equity

N/A

Revenue/Share

1.94 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BBI

A.I. Advisor

published General Information

General Information

a company, which engages in the development of prescription therapeutics for the treatment of skin diseases

Industry Biotechnology

Profile

Details

Industry

N/A

Address

5777 Central Avenue

Phone

+1 720 505-4755

Employees

16

Web

https://www.brickellbio.com